Loss of Non-Inherited Maternal MHC and Materno-Fetal Transmission of p190 Type BCR-ABL Leukemia.

Takeshi Isoda(Tokyo Medical and Dental University), Mel Greaves(Institute of Cancer Research), Hiroh Saji, Daisuke Tomizawa(National Center For Child Health and Development), Tomohiro Morio(Tokyo Institute of Psychiatry), Anthony M. Ford(Institute of Cancer Research), Noriko Mitsuiki(Tokyo Medical and Dental University), Tomohiko Taki(Kyorin University), Frederik W. van Delft(Newcastle University), David González de Castro(Complejo Hospitalario de Salamanca), Shuki Mizutani, Joannah Score(Salisbury District Hospital), Masatoshi Takagi(Tokyo Medical and Dental University)
Blood
November 20, 2009
10.1182/blood.v114.22.980.980
Cited by 1

Related Papers

Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
|Leukemia|2003|3k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
|The Lancet Oncology|2013|728